Medtronic Wins Dual Cardiac Clearances While MiniMed Swap and Robotics Push Reshape the Group

{
  "signal_id": "276d025b-1b86-2bef-43ff-46a8c9a67475",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-30T19:10:38+00:00",
  "company": {
    "name": "Medtronic",
    "domain": "medtronic.com"
  },
  "data": {
    "url": "https://www.ad-hoc-news.de/boerse/news/unternehmensnachrichten/medtronic-wins-dual-cardiac-clearances-while-minimed-swap-and-robotics/70206194",
    "title": "Medtronic Wins Dual Cardiac Clearances While MiniMed Swap and Robotics Push Reshape the Group - AD HOC NEWS",
    "excerpt": "Medtronic has secured a pair of regulatory green lights for its heart-rhythm franchise, even as a broader corporate overhaul and a fresh dividend declaration dominate the agenda for shareholders. The medical-technology group said it received FDA clearance and the CE mark for its Affera Prism-2 mapping software, and separately obtained CE certification for the PulseSelect ProxBox adapter, which carries integrated proximity-indicator software. Together the approvals deepen Medtronic's hand in cardiac ablation: Prism-2 adds tissue-mapping tools to the clinical toolkit, while the ProxBox adapter feeds physicians real-time feedback on tissue proximity, a feature meant to sharpen precision during cardiology procedures. Investors took the news in stride. The stock changed hands at EUR 76.50, a modest 0.4% decline, putting the company's market value at roughly EUR 100.01 billion. The muted reaction echoes a pattern of recent sessions in which product milestones have failed to jolt the share price. Insider activity offered another data point. Harry \"Skip\" Kiil, Executive Vice President and Cardiovascular President, sold 1,483 common shares on September 16 at USD 93.65 apiece. The mandatory disclosure listed a remaining holding of 42,186 shares. Should investors sell immediately? Or is it worth buying Medtronic? The cardiac clearances land amid a far-reaching strategic reset. Medtronic...",
    "summary": "Medtronic entered into a strategic partnership with Cornerstone Robotics valued at USD 700 million, which includes distribution rights for the Sentire surgical system in certain markets outside the U.S.",
    "planning": false,
    "image_url": "https://mdb.ad-hoc-news.de/bild/bild-2703863_1920_1080.webp",
    "confidence": 1,
    "published_at": "2026-09-30T19:10:38Z",
    "article_sentence": "Roughly a month ago Medtronic struck a strategic partnership worth USD 700 million with Cornerstone Robotics, a deal that includes distribution rights for the Sentire surgical system in selected markets outside the United States.",
    "amount_normalized": 700000000,
    "related_company_name": "Cornerstone Robotics",
    "related_company_domain": "cornerstonerobotics.com"
  }
}

curl https://signals.autobound.ai/v1/signals/276d025b-1b86-2bef-43ff-46a8c9a67475 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"medtronic.com","limit":20}'